The death effector domain protein family: Regulators of cellular homeostasis

Nature Immunology

Volumn 4, Issue 5, 2003, Pages 404-409

  Tibbetts, Michael D ^a   Zheng, Lixin ^a   Lenardo, Michael J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 10; CASPASE 8; FAS ANTIGEN; INHIBITOR OF APOPTOSIS PROTEIN; REGULATOR PROTEIN;

APOPTOSIS; AUTOIMMUNITY; CELL DEATH; CELL DIFFERENTIATION; CELL RENEWAL; CELLULAR DISTRIBUTION; HOMEOSTASIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CARRIER PROTEINS; CASPASE 8; CASPASE 9; CASPASES; CELL DIVISION; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; DNA-BINDING PROTEINS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HOMEOSTASIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 0038393124     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni0503-404     Document Type: Review

References (74)

1. Itoh, N. & Nagata, S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268, 10932-10937 (1993).
2. Tartaglia, L.A., Ayres, T.M., Wong, G.H. & Goeddel, D.V. A novel domain within the 55 kD TNF receptor signals cell death. Cell 74, 845-853 (1993).
3. Boldin, M.P. et al. A novel protein that interacts with the death domain of Fas/APO I contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798 (1995).
4. Chinnaiyan, A.M., O'Rourke, K., Tewari, M. & Dixit, V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512 (1995).
5. Fernandes-Alnemri, T. et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA 93, 7464-7469 (1996).
6. Muzio, M., Stockwell, B.R., Stennicke, H.R., Salvasen, G.S. & Dixit, V.M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273, 2926-2930 (1998).
7. Kischkel, F.C. et al. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J. Biol. Chem. 276, 46639-46646 (2001).
8. Martin, D.A., Siegel, R.M., Zheng, L. & Lenardo, M.J. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHα1) death signal. J. Biol. Chem. 273, 4345-4349 (1998).
9. Wang, J., Chun, H.J., Wong, W., Spencer, D.M. & Lenardo, M.J. Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl. Acad. Sci. USA 98, 13884-13888 (2001).
10. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V. & Wallach, D.I. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/Apo-1 and TNF receptor-induced cell death. Cell 85, 803-815 (1996).
11. Muzio, M. et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827 (1996).
12. Weber, C.H. & Vincenz, C. The death domain superfamily: a tale of two interfaces? Trends Biochem. Sci. 26, 475-481 (2001).
13. Eberstadt, M. et al. NMR structure and mutagenesis of the FADD (MORT1) death-effector domain. Nature 392, 941-945 (1998).
14. Hofmann, K. The modular nature of apoptotic signaling proteins. Cell. Mol. Life Sci. 55, 1113-1128 (1999).
15. Martinon, F., Hofman, K. & Tschopp, J. The pyrin domain: a possible member of the death domain family implicated in apoptosis and inflammation. Curr. Biol. 11, R118-R120 (2001).
16. Hofmann, K., Bucher, P. & Tschopp, J. The CARD domain: a new apoptotic signalling motif. Trends Biochem. Sci. 22, 155-156 (1997).
17. Garvey, T.L. et al. Binding of FADD and caspase-8 to molluscum contagiosum virus MC159 v-FLIP is not sufficient for its antiapoptotic function. J. Virol. 76, 697-706 (2002).
18. Hu, S. & Yang, X. dFADD, a novel death domain-containing adapter protein for the Drosophila caspase DREDD. J. Biol. Chem. 275, 30761-30764 (2000).
19. Lee, S.W., Ko, Y.G., Bang, S., Kim, K.S. & Kim, S. Death effector domain of a mammalian apoptosis mediator, FADD, induces bacterial cell death. Mol. Microbiol. 35, 1540-1549 (2000).
20. Siegel, R.M. et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288, 2354-2357 (2000).
21. Kaufmann, M. et al. Identification of a basic surface area of the FADD death effector domain critical for apoptotic signaling. FEBS Lett. 527, 250-254 (2002).
22. Weber, C.H. & Vincent, C. A docking model of key components of the DISC complex: death domain superfamily interactions redefined. FEBS Lett. 492, 171-176 (2001).
23. Rieux-Laucat, F. et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349 (1995).
24. Fisher, G.H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946 (1995).
25. Sneller, M.C. et al. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 89, 1341-1348 (1997).
26. Yang, X., Chang, H.Y. & Baltimore, D. Autoproteolytic activation of pro-caspases by oligomerization. Mol. Cell 1, 319-325 (1998).
27. Jaattela, M. & Tschopp, J. Caspase-independent cell death in T lymphocytes. Nat. Immunol. 4, 416-423.
28. Holler, N. et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1, 489-495 (2000).
29. Li, M. & Beg, A.A. Induction of necrotic-like cell death by tumor necrosis factor-α and caspase inhibitors: novel mechanism for killing virus-infected cells. J. Virol. 74, 7470-7477 (2000).
30. Bertin, J. et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNRF1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 1172-1176 (1997).
31. Hu, S., Vincenz, C., Buller, M. & Dixit, V.M. A novel family of viral death effector domain-containing molecules that inhibit both CD95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272, 9621-9624 (1997).
32. Thome, M. et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517-521 (1997).
33. Garvey, T.L., Bertin, J., Siegel, R.M., Lenardo, M.J. & Cohen, J. The death effector domains (DEDs) of the molluscum contagiosum virus MC159 v-FLIP protein are not functionally interchangeable with each other or with the DEDs of caspase-8. Virology 300, 217-225 (2002).
34. Irmler, M. et al. Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195 (1997).
35. Hu, S., Vincenz, C., Ni, J., Gentz, R. & Dixit, V.M. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-I- and CD-95-induced apoptosis. J. Biol. Chem. 272, 17255-17257 (1997).
36. Kreuz, S., Siegmund, D., Scheurich, P. & Wajant, H. NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol. 21, 3964-3973 (2001).
37. Michaeu, O., Lens, S., Gaide, O., Alevizopoulos, K. & Tschopp, J. NF-κB signals induce the expression of c-FLIP. Mol. Cell. Biol. 21, 5299-5305 (2001).
38. Thomas, R.K. et al. Constituitive expression of c-FLIP in Hodgkin and Reed-Sternberg cells. Amer. J. of Path. 160, 1521-1528 (2002).
39. L is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21, 3704-3714 (2002).
40. L modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol. Cell. Biol. 22, 5419-5433 (2002).
41. Condorelli, G. et al. PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNRF1-induced apoptosis. Oncogene 18, 4409-4415 (1999).
42. Kitsberg, D. et al. Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFα-induced apoptosis. J. Neuroscience 19, 8244-8251 (1999).
43. Araujo, H., Danziger, N., Cordier, J., Glowinski, J. & Chneiweiss, H. Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J. Biol. Chem. 268, 5911-5920 (1993).
44. Kubes, M., Cordier, J., Glowinski, J., Girault, J.A. & Chneiweiss, H. Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro. J. Neurochem. 71, 1307-1314 (1998).
45. Gomez-Angelats, M. & Cidlowski, J.A. Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis. J. Biol. Chem. 276, 44944-44952 (2001).
46. Xiao, C., Yang, B.F., Asadi, N., Beguinot, F. & Hao, C. Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J. Biol. Chem. 277, 25020-25025 (2002).
47. Estelles, A., Charlton, C.A. & Blau, H.M. The phosphoprotein PEA-15 inhibits Fas- but increases TNFR1 mediated caspase-8 activity and apoptosis. Dev. Biol. 216, 16-28 (1999).
48. Stegh, A.H. et al. DEDD, a novel death effector domain-containing protein, targeted to the nucleolus. EMBO J. 17, 5974-5986 (1998).
49. Schickling, O., Stegh, A.H., Byrd, J. & Peter, M.E. Nuclear localization of DEDD leads to caspase-6 activation through its death effector domain and inhibition of RNA polymerase I dependent transcription. Cell Death Differ. 8, 1157-1161 (2001).
50. Lee, J. et al. DEDD regulates degradation of intermediate filaments during apoptosis. J. Cell. Biol. 158, 1051-1066 (2002).
51. Roth, W., Stenner-Liewen, F., Pawlowski, K., Godzik, A. & Reed, J.C. Identification and characterization of DEDD2, a death effector domain-containing protein. J. Biol. Chem. 277, 7501-7508 (2002).
52. Zheng, L., Schickling, O., Peter, M.E. & Lenardo, M.J. The death effector domain-associated factor plays distinct regulatory roles in the nucleus and cytoplasm. J. Biol. Chem. 276, 31945-31952 (2001).
53. L and procaspase-8-associated protein in the endoplasmic reticulum. J. Cell Biol. 139, 327-338 (1997).
54. Zhang, H. et al. BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc. Natl. Acad. Sci. USA 97, 2597-2602 (2000).
55. L-expressing MCF7-Fas cells: role for bifunctional apoptosis regulator protein. J. Biol. Chem. 277, 4351-4360 (2002).
56. Nguyen, M., Breckenridge, D.G., Ducret, A. & Shore, G.C. Caspase-resistant BAF31 inhibits Fas-mediated apoptotic membrane fragmentation and release of cytochrome c from mitochondria. Mol. Cell. Biol. 20, 6731-6740 (2000).
57. Wang, B. et al. Uncleaved BAP31 in association with A4 protein at the endoplasmic reticulum is an inhibitor of Fas-initiated release of cytochrome c from mitochondria. J. Biol. Chem. advance online publication, 15 January 2003 (doi:10.1074/jbc.M209684200).
58. Siegel, R.M. et al. Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis. J. Cell. Biol. 141, 1243-1253 (1998).
59. Zhang, J., Cado, D., Chen, A., Kabra, N.H. & Winoto, A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392, 296-300 (1998).
60. Walsh, C.M. et al. A Role for FADD in T cell activation and development. Immunity 8, 439-449 (1998).
61. Newton, K., Harris, A.W., Bath, M.L., Smith, K.G. & Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17, 706-718 (1998).
62. Mack, A. & Hacker, G. Inhibition of caspase or FADD function blocks proliferation but not MAP kinase activation and interleukin-2 production during primary stimulation of T cells. Eur. J. Immunol. 32, 1986-1992 (2002).
63. Alam, A., Cohen, L.Y., Aouad, S. & Sekaly, R.F. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190, 1879-1890 (1999).
64. Kennedy, N.J., Kataoka, T., Tschopp, J. & Budd, R.C. Caspase activation is required for T cell proliferation. J. Exp. Med. 190, 1891-1896 (1999).
65. Chun, H. et al. Pleiotropic lymphocyte activation defects due to caspase-8 mutation causes human immunodeficiency. Nature 419, 395-399 (2002).
66. Chaudhary, P.M. et al. Activation of the NF-κB pathway by caspase 8 and its homologs. Oncogene 19, 4451-4460 (2000).
67. Hu, W.H., Johnson, H. & Shu, H.B. Activation of NF-κB by FADD, Casper, and Caspase 8. J. Biol. Chem. 275, 10838-10844 (2000).
68. Wang, J. et al. Inherited caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98, 47-58 (1999).
69. Kataoka, T et al. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10, 640-648 (2000).
70. Alderson, M.R. et al. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178, 1891-1896 (1993).
71. Ramos, J.W. et al. Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol. Biol. Cell 11, 2863-2872 (2000).
72. Formstecher. E. et al. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell 1, 239-250 (2001).
73. Ivanova, N.B. et al. A stem cell molecular signature. Science 298, 601-604 (2002).
74. Gervais, F.G. et al. Recruitment and activation of caspase-8 by the Huntington-interacting protein Hip-I and a novel partner Hippi. Nat. Cell Biol. 4, 95-105 (2002).